Skip to main content
. 2018 Oct 25;10(4):205. doi: 10.3390/pharmaceutics10040205

Table 1.

Five-year incidence and survival of bone metastases by tumor type [4,5].

Tumor Type % Incidence of Bone Metastases (95% CI) % 5-Year Survival (95% CI)
Prostate 24.5 (23.9–25.1) 6 (5 to 7)
Lung 12.4 (12.1–12.7) 1 (0.5 to 1)
Renal 8.4 (8.0–8.9) 5 (4 to 7)
Breast 6.0 (5.8–6.1) 13 (11 to 14)
Gastrointestinal 3.2 (3.0–3.4) 3 (2 to 5)